Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by 40Baggson Jan 05, 2019 4:13pm
195 Views
Post# 29190577

RE:RE:RE:RE:RE:From the PROF

RE:RE:RE:RE:RE:From the PROF I believe we will see a large equity buy around $15-20 this month. You cannot stop the mj juggernaught that is Aphria. Leaning towards Diageo with their $3B excess cash on hand. If they generate $2B cash per year and have allocated 550M from salzerac sale to the $3B stock rebuy, that leaves around $2.5B available for an equity buyin. Educated guess. GL


Bitofgreen wrote:  Simon, in his assessment said Aphria has the goods to go alone so that also speaks volumes. His pedigree is strong and well-respected dealing with the likes of Carl Ichan who invested in him.  It also appears other LP’s are failing with product commitments. We should be negotiating from a position of strength and I would like to see a 15-25% equity buy in. Giving the farm away is not smart right now, but we do need to protect our flank.

INVSTIGAT0R wrote:
If another offer is made it needs to be a really good one. If it's a full buyout, let's not be stupid and say yes to some weak-a.ss mid-teens offer, Aphria is worth way more than that and we shouldn't be looking for a small and fast return. If Aphrias fair market value is closer to $16 right now, while also considering what Cronos was valued at, we need to demand $24+ to satisfy all the bag holders here. It is only fair. I'd rather a cash injection and partner because there is way more upside if that happens. I don't mind a cash injection at $18.




Bullboard Posts